50 Participants Needed

Attentional Bias Modification Training for Quitting Smoking

HJ
SH
Overseen BySeok Hyun Gwon, PhD, RN
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Wisconsin, Milwaukee

Trial Summary

What is the purpose of this trial?

Aims are to (1) evaluate attentional bias to e-cigarette cues between the intervention and control groups at post-intervention as compared to the pre-intervention; and (2) test the feasibility and efficacy of the intervention at post-intervention. To accomplish these aims, a theory-driven parallel, controlled 2-arm randomized clinical trial will be conducted with young adult e-cigarette users (approximately N = 50). Outcomes are attentional bias to e-cigarette cues and abstinence outcomes including nicotine dependence, and arousal/urges for e-cigarette use.

Research Team

SH

Seok Hyun Gwon, PhD, RN

Principal Investigator

University of Wisconsin, Milwaukee

Eligibility Criteria

This trial is for young adults aged 18-29 who exclusively use e-cigarettes (ENDS) and have been doing so for at least 3 months. Participants must own a smartphone but cannot be on medication or psychosocial treatment for ENDS dependence, pregnant, have serious alcohol issues, eye-tracking problems, or current psychiatric treatment for DSM-5 mental health disorders.

Inclusion Criteria

I have only used electronic nicotine devices for the last 3 months.
Ownership of a smartphone
I am between 18 and 29 years old.

Exclusion Criteria

I have eye conditions that affect my ability to follow moving objects.
I am receiving treatment for a mental health disorder listed in the DSM-5.
Pregnancy
See 2 more

Treatment Details

Interventions

  • Computerized attentional bias modification training
  • Placebo attention control training
Trial OverviewThe study tests if computerized attentional bias modification training can change how much participants pay attention to e-cigarette cues and help them quit smoking compared to a placebo control group. About 50 young adult e-cigarette users will be randomly assigned to one of the two groups in this controlled trial.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Computerized attentional bias modification trainingExperimental Treatment1 Intervention
Group II: Placebo attention control trainingPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wisconsin, Milwaukee

Lead Sponsor

Trials
52
Recruited
6,200+